[HTML][HTML] 5-Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells

S Matsusaka, I Wakabayashi - FEBS letters, 2005 - Elsevier
S Matsusaka, I Wakabayashi
FEBS letters, 2005Elsevier
The purpose of the present study was to investigate whether 5-hydroxytryptamine (5-HT,
serotonin) affects migration of vascular endothelial cells. 5-HT significantly enhanced
migration of human aortic endothelial cells (HAECs), and this enhancement was completely
inhibited by GR 55562, a 5-HT1 receptor antagonist, and fluoxetine, a 5-HT transporter
inhibitor, but was not affected by ketanserin, a 5-HT2 receptor antagonist. 5-HT stimulation
increased RhoA and ERK activity of HAECs, and inhibitors of RhoA (Y-27632 and H-1152) …
The purpose of the present study was to investigate whether 5-hydroxytryptamine (5-HT, serotonin) affects migration of vascular endothelial cells. 5-HT significantly enhanced migration of human aortic endothelial cells (HAECs), and this enhancement was completely inhibited by GR 55562, a 5-HT1 receptor antagonist, and fluoxetine, a 5-HT transporter inhibitor, but was not affected by ketanserin, a 5-HT2 receptor antagonist. 5-HT stimulation increased RhoA and ERK activity of HAECs, and inhibitors of RhoA (Y-27632 and H-1152) and inhibitors of MEK (U0126 and PD98059) abolished the 5-HT-induced increase in migration velocity. Inhibition of Rho kinase by Y-27632 blocked stress fiber formation and rear release of HAECs. Thus, 5-HT has a potent enhancing action on migration of HAECs through activating the RhoA and ERK pathways following 5-HT1 receptor stimulation.
Elsevier